In the present study, we describe a novel inhibitory receptor, leukocyte-associated immunoglobulin-like receptor-1 (LAIR-1), that is constitutively expressed on the majority of human peripheral blood mononuclear leukocytes. LAIR-1 is a 32 kDa transmembrane glyco protein with a single immunoglobulin-like domain and a cytoplasmic tail containing two immune receptor tyrosine-based inhibitory motifs. LAIR-1 recruits SHP-1 and SHP-2 phosphatases upon activation, and crosslinking of the LAIR-1 antigen on natural killer (NK) cells results in strong inhibition of NK cell-mediated cyto toxicity. Although it is structurally related to human killer cell inhibitory receptors, LAIR-1 does not appear to recognize human leukocyte antigen (HLA) class I molecules and thus represents a novel HLA class Iindependent mechanism of NK cell regulation. i Correspondence should be addressed to J. H. P. We thank Jim Cupp and Erin Murphy for flow cytometry, Allison Helms, and Connie Huffine for DNA sequencing; Debra Liggett for oligonucleotide syn thesis;
Introduction Natural killer (NK) cells are a subpopulation of lympho cytes distinct from T and B cells. NK cells are capable of lysing transformed and virus-infected cells without apparent presensitization, and are considered important cellular components of innate immunity (reviewed by
. The molecular interactions that trigger the cytolytic functions of NK cells are not completely understood. Monoclonal antibodies (MAbs) recognizing adhesion and signaling molecules, however, have been shown to induce NK cell-mediated cytotoxicity in vitro (Siliciano et a l./1985; Lanier et al., 1988b; Moretta et al., 1991; Shibuya et al., 1996) .
In recent years, progress has been made in under standing the receptors responsible for inhibiting NK cell functions. The early observation that NK cells selectively kill targets that lack major histocompatibility complex (MHC) on their surface (Karre et al., 1986) , eventuallŷ led to the identification of inhibitory receptors present on NK cells that bind MHC expressed on the target cell. In humans, two separate families of inhibitory receptors have been identified on NK cells: killer cell inhibitory receptors (KIRs), which are immunoglobulin superfamily members (Colonna and Samaridis, 1995; D'Andrea et al., 1995; Wagtmann et al., 1995; Lanier and Phillips, 1996) , and the CD94/NKG2 receptors of the C-type lec tin superfamily (Lazetic et al., 1996; Sivori et al., 1996) . All of these inhibitory receptors pos sess cytoplasmic tails with immune receptor tyrosinebased inhibitory motifs (ITIMs) (Thomas, 1995) . Upon phosphorylation, cytoplasmic ITIMs bind the SH2 do mains of certain phosphatases, leading to down-regulation of cell activation (Scharenberg and Kinet, 1996) .
To identify molecules important in the regulation of NK cell cytotoxicity, we immunized mice with human NK cells and screened for MAbs that were capable of inhibiting NK cell mediated cytotoxicity. A MAb, desig nated DX26, that when cross-linked delivered a negative signal to NK cells, was identified. The antigen recog nized by DX26 MAb (designated leukocyte-associated immunoglobulin-like receptor-1 [LAIR-1]) is a member of the immunoglobulin superfamily, with homology to KIRs, and possesses two ITIMs in its cytoplasmic do main. LAIR-1, however, does not appear to recognize class I human leukocyte antigens (HLA) and thus repre sents a novel (HLA-independent) inhibitory molecule that may play an important role in the regulation of NK cell function.
Results

DX26 Identifies an Inhibitory Receptor on NK Cells
To identify molecules that are involved in negative sig naling, mice were immunized with a human NK cell clone and antibodies were screened for their capacity to inhibit NK cell-mediated lysis of Fc-receptor (FcR)-bearing tar gets. A MAb, designated DX26, was isolated that effi ciently inhibited the NK cell-mediated cytotoxicity of the human Fc^/Rll (CD32) transfected Epstein-Barr virus (EBV)-transformed B cell line, 721.221/CD32 (Figure 1) . Cytolysis of the FcR-negative parent line, 721.221, how ever, was not affected by DX26 MAb, indicating that FcR cross-linking of LAIR-1 (the antigen recognized by DX26 MAb) was required to deliver the negative signal ( Figure 1 ). Further evidence for the inhibitory signaltransducing capabilities of LAIR-1 was obtained using the FcR-expressing mouse mastocytoma cell line, P815. Many NK cell clones lyse P815 in the presence of MAbs against positive signal molecules, such as CD2, CD16, CD69, and DNAM-1 (Lanier et al., 1997) . Antibody-medi ated NK cell lysis of P815 was also inhibited by DX26 MAb, indicating that cross-linking of LAIR-1 led to inhibi tion of cytotoxicity, even in the presénce of strong posi tive signals (Figure 2) .
Since the majority of resting NK cells express LAIR-1, experiments were undertaken to determine whether LAIR-1 functions as an inhibitory receptor on freshly isolated NK cells. Resting NK cells were purified from peripheral blood to greater than 90% purity and assayed for cytolysis of anti-CD16 MAb-coated P815 in the pres ence or absence of DX26 MAb. As was observed with NK cell clones, freshly isolated NK cell cytolysis of anti-CD16 coated P815 was significantly inhibited by the presence of DX26 MAb ( Figure 3A) . Cytolysis of the NK-sensitive tumor cell line K562 by NK cells in freshly isolated peripheral blood mononuclear cells (PBMCs) was also inhibited by DX26 MAb (Figure 3B ). DX26 F(ab)'2 fragments did not affect killing of K562, which further substantiates the necessity for LAIR-1 to be cross-iinked in order to generate a negative signal in NK cells. Likewise, NK cell cytotoxicity against a panel of FcR-negative tumor cells was unaffected by the pres ence of the DX26 MAb (data not shown).
LAIR-1 Is a Broadly Expressed Leukocyte Antigen
Phenotypic analysis of human peripheral blood lympho cytes demonstrated that LAIR-1 is a widely expressed molecule on peripheral blood leukocytes. LAIR-1 is prominently expressed on norma! peripheral blood CD3+CD4+ 1 cells (70% -80% ), CD3+CD8+ Tcells (80%-90%), CD3 "CD56+ NK celts (95%-100%), CD3CD19+ B cells (80%-90%), and CD3"CD14+ monocytes (99% -100%) ( Figures 4A-4C ). LAIR-1, however, was not ex pressed on peripheral blood granulocytes, platelets, or red blood cells (data not shown). The majority of human fetal thymocytes, also expressed LAIR-1 ( Figure 4D ), as well as all NK cell and T cell clones and all T cell tumor cell lines (Table 1 ). The long-term cultured NK lines, NKL and NK92, were negative for LAIR-1 , as were EBVtransformed B cell lines, the B cell tumor Daudi, the NKlike tumor cell line YT, and several nonhematopoietic cell lines (Table 1) .
cDNA Cloning of LAIR-1 To identify a LAIR-1-encoding cDNA, 293T cells were transfected with a cDNA library prepared from a poly clonal human NK cell line (Lanier et al., 1994) , and ex pression cloning using flow cytometry was performed. As shown in Figure 5A Figure 7) . This smaller protein also decreased in size after deglycosylation. Whether this represents a distinct LAIR-1 isoform or a proteolytic cleavage product of LAIR-1 is unknown.
LAIR-1 Binds SHP-1 and SHP-2
The existence of two consensus sequences for ITIMs within the cytoplasmic domain of LAIR-1 suggested that the generation of an inhibitory signal in NK cells was manifested by the recruitment of SH2-containing tyro sine phosphatases-1 and/or -2 (SHP-1 and/or SHP-2).
To determine whether LAIR-1 was capable of binding protein tyrosine phosphatases, a NK cell clone was stim ulated with pervanadate (an inhibitor of protein tyrosine phosphatases that induces tyrosine phosphorylation tions with DX26 MAb identified two proteins with slightly different molecular weights after deglycosylation. We have recently identified, by colony hybridization of a T cell-derived cDNA library, a putative family member of LAIR-1, which we have designated LAIR-2 (EMBL/Gen-Bank/DDBJ accession number AF013250). LAIR-2 con tains one immunoglobulln-like domain, which is 84% homologous to LAIR-1; however, it lacks both a trans membrane and a cytoplasmic domain, suggesting that LAIR-2 is a secreted protein (data not shown). Further studies are required to delineate the functions of LAIR-2 as well as to define other possible LAIR-1 family members. We have not yet defined the ligand(s) for LAIR-1. Since C TGGCC TC TGCACCTGAGGGTAG AAAGTCACTCTAGGAAAAGCC TGAAGCAGC CATTTG 1 0 0 3 GAAGGCTTCCTGTTGGATTCCTCTTCATCTAGAAAGCCAGCCAGGCAGCTGTCGTGGAG 1 0 6 2 ACAAGAGCTGGAGACTGGAGGTTTCTAACCAGCATCCAGAAGGTTCGTTAGCCAGGTGG 1 1 2 1 TCCCTTCTACAATCGAGCAGCTCCTTGGACAGACTGTTTCTCAGTTATTTCCAGAGACC 1 1 8 0 CAGCTACAGTTCCCTGGCTGTTTCTAGAGACCCAGCTTTATTCACCTGACTGTTTCCAG 1 2 3 9 AGACCCAGCTAAAGTCACCTGCCTGTTCTAAAGGCCCAGCTACAGCCAATCAGCCGATT 1 2 9 8 TCCTGAGCAGTGATGCCACCTCCAAGCTTGTCCTAGGTGTCTGCTGTGAACCTCCAGTG 1 3 5 7 ACCCCAGAGACTTTGCTGTAATTATCTGCCCTGCTGACCCTAAAGACCTTCCTAGAAGT 1 4 1 6 CAAGAGCTAGCCTTGAGACTGTGCTATACACACACAGCTGAGAGCCAAGCCCAGTTCTC 1 4 7 5 TGGGTTGTGCTTTACTCCACGCATCAATAAATAATTTTGAAGGCCTCACATCTGGCAGC 1 5 3 4 CCCAGGCCTGÇTCCTGGGTGCATAGGTCTCTCGGACCCACTCTCTGCCTTCACAGTTGT 1 5 9 3 TCAAAGCTGAGTGAGGGAAACAGGACTTACGAAAACGTGTCAGCGTTTTCTTTTTAAAA 1 6 5 2 TTTAAT TG ATC AGGATTGTAC GTAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAA 1 7 1 1 AAAAAAAAAAAAAAAGG the DX26 MAb does not interfere with HLA class I recog nition by a large panel of NK clones (data not shown), it seems unlikely that LAIR-1 recognizes HLA class I molecules. Furthermore, since LAIR-1 is broadly ex pressed on the majority of mononuclear leukocytes, its ligand(s) may demonstrate a more restricted expression. Experiments are presently underway using LAIR-1 fu sion proteins to probe various tissues and cell types for potential ligands for this inhibitory receptor. At present, we have studied the function of LAIR-1 only on peripheral blood NK cells. DX26 MAb also stains peripheral blood B cells, T cells, and monocytes as well as the majority of thymocytes. The functional signifi cance of the molecules recognized by DX26 MAb on these other mononuclear leukocytes remains to be de termined. However, it is reasonable to predict that LAIR-1, or closely related family members, will be found to provide a mechanism of regulation in a variety of immune interactions. Blood Center (Stanford, CA) . PBMCs were isolated by Ficoll-Hypaque centrifugation. Resting NK cells were purified from PBMCs by magnetic bead depletion as described (Phillips et al., 1992) .
Experimental Procedures
Cells Peripheral blood from healthy donors was purchased from Stanford
NK clones were established as described ( 
Cytotoxicity Assay
Cell lines were labeled with51 Cr and used as targets in a 4 hr radioiso tope release assay as described (Lanier et alM 1983) , Data are ex pressed as the mean of triplicate cultures. Spontaneous radioiso tope release did not exceed 1 0 % of maximum release as determined by lysis of target cells with 10% Triton-X 100, The percentage spe cific lysis was calculated as (cpm specific 51Cr release -cpm spon taneous 51Cr release)/(cpm maximum 51Cr release -cpm spontane ous 51 Cr release) x 1 00.
Expression Cloning
A cDNA library was constructed from an interleu kin-2-dependent polyclonal NK line, as described (Lanier et al., 1994) . cDNA cloning by transient expression in 293T cells was performed as described (Aruffo and Seed, 1987) , with modifications (Lanier et a!., 1994) . LAIR-1, a Novel Inhibitory Receptor 289 by a procedure described previously (Lanier et aL, 1988a) . Immuno precipitates were separated by SDS-PAGE and visualized by expo sure to a phosphoimager screen. To demonstrate association of phosphatases with phosphorylated LAIR-1, NK cells were stimulated with 100 mM sodium pervan adate for 10 min at 37°C (O'Shea et al., 1992). Cells were lysed in 1 % NP40 in the presence of phosphatase inhibitors as described . LAIR-1 protein was immunoprecipitated by DX26 MAb and protein G-sepharose (Pharmacia, Alameda, CA). Immunoprecipitates were separated by SDS-PAGE and transferred to Immobilon-P membranes (Millipore, Bedford, MA) . The mem branes were blocked and incubated with polyclonal rabbit antibod ies against SHP-1 and SHP-2 (C18 and C19, Santa Cruz Labora tories), followed by horseradish peroxidase conjugated anti-rabbit immunoglobulin (Amersham, Arlington Heights, IL). Proteins were detected by enhanced chemiluminescence (Supersignal Substrate, Pierce, IL).
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